Last updated: 11/04/2018 13:50:08

The effects of potassium nitrate in reducing dentinal hypersensitivity

GSK study ID
Z3770631
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: An exploratory study investigating the effects of a potassium nitrate solution in reducing dentinal hypersensitivity
Trial description: A randomized, controlled, double blind exploratory study to explore the effects of two different potassium nitrate concentrations and water on exposed dentine in reducing dentinal hypersensitivity. Solutions will be applied for either 2, 5 or 10 minutes and assessed by visual analogue scale (VAS) scores following evaporative (air) stimulus.
Primary purpose:
Treatment
Trial design:
Crossover Assignment
Masking:
Double (Participant, Investigator)
Allocation:
Randomized
Primary outcomes:

Adjusted mean change from baseline in evaporative sensitivity pain response of hypersensitive tooth on a visual analogue scale (VAS) immediately post application of 5% KNO3 solution, 2.5% KNO3 solution and sterile water

Timeframe: Baseline, immediately post administration of treatment

Adjusted mean change from baseline in evaporative sensitivity pain response of hypersensitive tooth on a VAS, 10 minutes post application of 5% KNO3 solution, 2.5% KNO3 solution and sterile water

Timeframe: Baseline, 10 minutes post administration of treatment

Adjusted mean change from baseline in evaporative sensitivity pain response of hypersensitive tooth on a VAS, 20 minute post application of 5% KNO3 solution, 2.5% KNO3 solution and sterile water

Timeframe: Baseline, 20 minutes post administration of treatment

Secondary outcomes:
Not applicable
Interventions:
  • Drug: Potassium Nitrate
  • Drug: Placebo
  • Enrollment:
    12
    Primary completion date:
    2009-30-04
    Observational study model:
    Not applicable
    Time perspective:
    Not applicable
    Clinical publications:
    Not applicable
    Medical condition
    Dentinal Hypersensitivity
    Product
    potassium nitrate
    Collaborators
    Not applicable
    Study date(s)
    February 2009 to April 2009
    Type
    Interventional
    Phase
    1

    Participation criteria

    Sex
    Female & Male
    Age
    18 - 65 years
    Accepts healthy volunteers
    No
    • General Health and Oral Heath: Good general health and oral health with (in the opinion of the investigator) no clinically significant and relevant abnormalities of medical history.
    • Teeth: Presence of teeth in various locations in the mouth to determine stent success. Required teeth include: at least three first molars; a maxillary incisor, cuspid and bicuspid; and a mandibular incisor, cuspid and bicuspid.
    • Allergy/Intolerance: Known or suspected intolerance or hypersensitivity to the stent materials (or closely related compounds) or any of their stated ingredients.
    • Condition of the Dentition: a) Sensitive teeth not expected to respond to treatment with an over-the-counter (OTC) dentifrice in the opinion of the investigator. b) Teeth with exposed dentine but with deep, defective or facial restorations, teeth used as abutments for fixed or removable partial dentures, teeth with full crowns, orthodontic bands, extensive caries or cracked enamel. Sensitive teeth with contributing aetiologies other than erosion, abrasion or recession of exposed dentine.

    Trial location(s)

    Location
    Status
    Contact us
    Contact us
    Location
    University Park Research Center (UPRC)
    Fort Wayne, IN, United States, 46825
    Status
    Study Complete

    Study documents

    Scientific result summary
    Available language(s): English

    If you wish to request for full study report, please contact - [email protected]

    Results overview

    Results posted on ClinicalTrials.gov

    Recruitment status
    Study complete
    Actual primary completion date
    2009-30-04
    Actual study completion date
    2009-30-04

    Plain language summaries

    Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.

    Additional information about the trial

    Additional information
    Not applicable
    Participate in clinical trial
    Access to clinical trial data by researchers
    Visit website